Cardiovascular DiseasesHEALNCT03670524
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
A study testing Greenness as a therapeutic intervention in people with Cardiovascular Diseases and Metabolic Health, run by University of Louisville at 1 site in United States.
Trial summary
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood… Read more about this study
- Who is it for?
- Ages 30 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases, Metabolic Health
- What is being tested?
- Greenness as a therapeutic intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 835 participants
- Where
- 1 siteUnited States
- Study dates
- 3 May 2018to 30 Oct 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 30-70 years of age.
- Live within the targeted study location
Who cannot join
- Unwilling or unable to provide consent.
- HIV/AIDS, active treatment for cancer, active bleeding including wounds.
- Body weight less than 100 pounds or BMI>40.
- Prisoners and other vulnerable populations.
- Anyone that PI thinks is unsafe to participate in study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Louisville
Louisville, Kentucky, 40202
Jackie Gallagher, MS, 502-852-6167, jacqueline.gallagher@louisville.edu
Rachel Keith, PhD
About this study
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
- Conditions
- Cardiovascular Diseases, Metabolic Health
- Being tested
- Greenness as a therapeutic intervention
- Medical subject headings
- Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Greenness as a therapeutic interventionOther
Greenness to be used as a therapeutic intervention
| Study group | Role | What they receive |
|---|---|---|
| Targeted neighborhoods for Greenness | Experimental | Using greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting. Receives: Other: Greenness as a therapeutic intervention |
| Control Group | No intervention | No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup.
Augmentation index-percent
Measured: Baseline and 2 year followup
Secondary outcomes (28)
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Blood pressure mm Hg
Measured: Baseline and 2 year followup
Physical Exam
Body weight-pounds
Measured: Baseline and 2 year followup
Body lean mass
Body lean mass to be measured in pounds
Measured: Baseline and 2 year followup
Body fat
Body fat to be measured in percentage
Measured: Baseline and 2 year followup
Standing height
standing height reported in inches
Measured: Baseline and 2 year followup
Waist, Hip measurement
central adiposity (waist circumference, and hip circumference to be measured in inches
Measured: Baseline and 2 year followup
Respiratory status will be evaluated
Fleisch-type pneumotachometer used to evaluate FEV1 and FVC percentages
Measured: Baseline and 2 year followup
Bucchal swab
Assess oral microbiome and DNA from cheek swab will be stored for genetic phenotyping.
Measured: Baseline and 2 year followup
Urine collection
metabolites of environmental volatile organic compounds ng/mg creatinine, biogenic VOCs and nicotine metabolites ng/mg creatinine, catecholamines ng/mg creatinine
Measured: Baseline and 2 year followup
Lipids
LDL-mg/dl, HDL-mg/dl, total cholesterol-mg/dl
Measured: Baseline and 2 year followup
Toenail samples
Toenail samples to look for heavy metal exposure
Measured: Baseline and 2 year followup
Hair samples
Hair samples to look at cortisol levels over time.
Measured: Baseline and 2 year followup
Perceived stress scale-PSS-10 range 0-40
The higher the score the more perceived stress
Measured: Baseline and 2 year followup
Depression-Patient Health Questionnaire (PHQ-9) 0-27
The 0-4= none; 5-9= Mild, 10-14= Moderate; 15-19= moderately severe; 20-27= severe. The higher the score the more severe the depression.
Measured: Baseline and 2 year followup
Well-being assessment-Questionnaire 13-65
Warwick-Edinburgh Mental Well-being scale 13-65. The higher the score the higher the sense of well-being.
Measured: Baseline and 2 year followup
Health perception
Health perception questionnaire
Measured: Baseline and 2 year followup
National Health Interview Survey tobacco questionnaire
National Health Interview Survey tobacco questionnaire
Measured: Baseline and 2 year followup
The Alcohol Use disorders identification test (AUDIT)- Range 0-40
Scores of 8-15 or more are recommended indicators of hazardous and harmful alcohol use or possible alcohol dependence. Women can be lowered to a score of 7 for concern. Scores of 16-19 suggest a need for brief counseling and continues monitoring. Scores of 20 or above warrant diagnostic evaluation for alcohol dependence.
Measured: Baseline and 2 year followup
Self reported physical activity 1
times per week
Measured: Baseline and 2 year followup
Self reported physical activity 2
Exertion level of mild moderate or vigorous
Measured: Baseline and 2 year followup
Self reported education
Education to be reported by last school grade completed
Measured: Baseline and 2 year followup
Self reported annual income
Annual income reported by dollars
Measured: Baseline and 2 year followup
Platelet count
cells/cubic millimeter
Measured: Baseline and 2 year followup
Complete Blood Count 1
White/Red blood cell count- cells per cubic millimeter
Measured: Baseline and 2 year followup
Complete Blood Count 2
Hemoglobin-grams/deciliter
Measured: Baseline and 2 year followup
Complete Blood Count 3
Hematocrit-percentage
Measured: Baseline and 2 year followup
Liver function
AST, ALT units per liter
Measured: Baseline and 2 year followup
C-Reactive Protein
Hs-CRP-mg/Liter
Measured: Baseline and 2 year followup
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Sep 2018
- Study start3 May 2018
- Primary completion1 Oct 2027 (estimated)
- Study completion30 Oct 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- More trials run by University of LouisvilleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- A unique pragmatic interventional trial with longitudinal follow up to assess the cardiovascular effects of increasing residential greenery.
- Masking
- None (open label)
- Enrolment
- 835 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Louisville
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute of Environmental Health Sciences (NIEHS), The Nature Conservancy
- Responsible party
- Principal investigator, Rachel Keith, University of Louisville
- Investigators
- Aruni Bhatnagar, PhD, Study director, University of LouisvilleRachel Keith, PhD, Principal investigator, University of Louisville
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03670524
- Sponsor's protocol ID
- 15.1260
- Other IDs
- R01ES029846-01
- Acronym
- HEAL
- Status last verified
- Feb 2026
- First submitted
- 31 Aug 2018
- Last updated
- 10 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Bhatnagar A, Keith R, Yeager R, Riggs D, Sears C, Bucknum B, Smith T, Fleischer D, Chandler C, Walker KL, Hart JL, Srivastava S, Turner J, Rai S. The Green Heart Project: objectives, design, and methods. Am J Epidemiol. 2026 May 7;195(5):1416-1428. doi: 10.1093/aje/kwae458.
PubMed 39691946McLeish AC, Smith T, Riggs DW, Hart JL, Walker KL, Keith RJ, Anderson L, Sithu I, Pinilla-Baquero J, Srivastava S, Bhatnagar A. Community-Based Evaluation of the Associations Between Well-Being and Cardiovascular Disease Risk. J Am Heart Assoc. 2022 Nov 15;11(22):e027095. doi: 10.1161/JAHA.122.027095. Epub 2022 Nov 12.
PubMed 36370026
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- ClinicalTrials.gov ID
- NCT03670524
- Acronym / sponsor ID
- HEAL / 15.1260
- Conditions
- Cardiovascular Diseases, Metabolic Health
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 835 participants (estimated)
- Lead sponsor
- University of LouisvilleUniversity, hospital or other
- Collaborators
- National Institute of Environmental Health Sciences (NIEHS), The Nature Conservancy
- Study start
- 3 May 2018 (actual)
- Primary completion
- 1 Oct 2027 (estimated)
- Study completion
- 30 Oct 2028 (estimated)
- First posted
- 13 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to examine how the environment and neighborhood characteristics affects the health of the area residents. The study will help determine how changing neighborhood characteristics, such as green space, affect heart health, risk factors for other diseases, sense of well- being or neighborhood cohesion.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- A unique pragmatic interventional trial with longitudinal follow up to assess the cardiovascular effects of increasing residential greenery.
| Arm | Type | Receives |
|---|---|---|
| Targeted neighborhoods for Greenness | Experimental | Other: Greenness as a therapeutic interventionUsing greenness as a therapeutic intervention, we will plant shrubs, grasses, young and mature trees (40-50 ft in height), so that we can evaluate changes in health and pollution, 2 years after planting. |
| Control Group | No intervention | –No intervention |
Who may qualify
- Ages
- 30 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- 30-70 years of age.
- Live within the targeted study location
Key exclusion criteria (5 listed)
- Unwilling or unable to provide consent.
- HIV/AIDS, active treatment for cancer, active bleeding including wounds.
- Body weight less than 100 pounds or BMI>40.
- Prisoners and other vulnerable populations.
- Anyone that PI thinks is unsafe to participate in study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Greenness as a therapeutic interventionGreenness to be used as a therapeutic intervention | Other | Targeted neighborhoods for Greenness |
Primary outcome
Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup.
Time frame: Baseline and 2 year followup
Augmentation index-percent
28 secondary outcomes
Cardiovascular Measurements. Change from Baseline Systolic and Diastolic pressures at baseline and 2 year followup.
Time frame: Baseline and 2 year followup
Physical Exam
Time frame: Baseline and 2 year followup
Body lean mass
Time frame: Baseline and 2 year followup
Body fat
Time frame: Baseline and 2 year followup
Standing height
Time frame: Baseline and 2 year followup
Waist, Hip measurement
Time frame: Baseline and 2 year followup
Respiratory status will be evaluated
Time frame: Baseline and 2 year followup
Bucchal swab
Time frame: Baseline and 2 year followup
Urine collection
Time frame: Baseline and 2 year followup
Lipids
Time frame: Baseline and 2 year followup
Toenail samples
Time frame: Baseline and 2 year followup
Hair samples
Time frame: Baseline and 2 year followup
Perceived stress scale-PSS-10 range 0-40
Time frame: Baseline and 2 year followup
Depression-Patient Health Questionnaire (PHQ-9) 0-27
Time frame: Baseline and 2 year followup
Well-being assessment-Questionnaire 13-65
Time frame: Baseline and 2 year followup
Health perception
Time frame: Baseline and 2 year followup
National Health Interview Survey tobacco questionnaire
Time frame: Baseline and 2 year followup
The Alcohol Use disorders identification test (AUDIT)- Range 0-40
Time frame: Baseline and 2 year followup
Self reported physical activity 1
Time frame: Baseline and 2 year followup
Self reported physical activity 2
Time frame: Baseline and 2 year followup
Self reported education
Time frame: Baseline and 2 year followup
Self reported annual income
Time frame: Baseline and 2 year followup
Platelet count
Time frame: Baseline and 2 year followup
Complete Blood Count 1
Time frame: Baseline and 2 year followup
Complete Blood Count 2
Time frame: Baseline and 2 year followup
Complete Blood Count 3
Time frame: Baseline and 2 year followup
Liver function
Time frame: Baseline and 2 year followup
C-Reactive Protein
Time frame: Baseline and 2 year followup
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2026.
- Derived from this study: PubMed 39691946Bhatnagar A, Keith R, Yeager R, Riggs D, Sears C, Bucknum B, Smith T, Fleischer D, Chandler C, Walker KL, Hart JL, Srivastava S, Turner J, Rai S. The Green Heart Project: objectives, design, and methods. Am J Epidemiol. 2026 May 7;195(5):1416-1428. doi: 10.1093/aje/kwae458.
- Derived from this study: PubMed 36370026McLeish AC, Smith T, Riggs DW, Hart JL, Walker KL, Keith RJ, Anderson L, Sithu I, Pinilla-Baquero J, Srivastava S, Bhatnagar A. Community-Based Evaluation of the Associations Between Well-Being and Cardiovascular Disease Risk. J Am Heart Assoc. 2022 Nov 15;11(22):e027095. doi: 10.1161/JAHA.122.027095. Epub 2022 Nov 12.
- Individual participant dataSharing planned: No
Related trials for Cardiovascular Diseases
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Aruni Bhatnagar, PhD study director
University of Louisville
Rachel Keith, PhD principal investigator
University of Louisville
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Greenness as a therapeutic intervention in people with Cardiovascular Diseases and Metabolic Health, run by University of Louisville at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jackie Research Coordinator, MS (502-852-6167, jacqueline.gallagher@louisville.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pulse Wave Analysis. Assess change from baseline arterial stiffness measurement and 2 year followup. (time frame: Baseline and 2 year followup). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03670524, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.